Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for HEPATITIS B SURFACE ANTIGEN

Ingredient

HEPATITIS B SURFACE ANTIGEN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
ENGERIX-B	20MCG	SUSPENSION	Resolved	2020-02-03	2020-03-25	105174
ENGERIX-B	20MCG	SUSPENSION	Resolved	2022-03-15	2022-04-01	156733
ENGERIX-B	20MCG	SUSPENSION	Resolved	2023-10-19	2023-11-22	207381
ENGERIX-B	20MCG	SUSPENSION	Resolved	2025-10-10	2025-11-14	269359
ENGERIX-B	10MCG	SUSPENSION	Resolved	2018-05-17	2018-11-30	49681
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	Actual shortage	2026-03-18	2026-03-18	280781
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	Resolved	2025-11-03	2026-04-18	270854
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	Resolved	2024-01-10	2024-02-14	215470
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	Resolved	2022-11-24	2023-05-12	175542
RECOMBIVAX HB	40MCG	SOLUTION	Resolved	2017-08-11	2017-10-07	18922

Showing 11 to 20 of 36

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
ENGERIX-B	20MCG	SUSPENSION	Discontinued	2019-12-10	2020-05-27	100904
ENGERIX-B	10MCG	SUSPENSION	Discontinued	2019-12-10	2020-04-30	100907
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	To be discontinued	2026-03-27	2026-04-01	281666
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	Discontinued	2026-03-27	2026-04-18	281670
RECOMBIVAX HB	10MCG	SUSPENSION SOLUTION	To be discontinued	2026-03-27	2026-04-01	281676

1

Showing 1 to 5 of 5